Phytocompounds-Based Formulations for Anti-Inflammatory Disorders
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 10 May 2025 | Viewed by 763
Special Issue Editor
Interests: phytochemistry; natural compounds; anti-inflammatory activity; antioxidant activity; formulation development
Special Issue Information
Dear Colleagues,
Inflammation is a complex biological process that occurs in response to injury, infection, or other stimuli. It is essential for the body to protect itself and initiate repair. However, in certain conditions, the inflammatory process may reach such intensity or duration that it becomes undesirable for the patient. Phytocompounds offer a promising avenue for the development of novel anti-inflammatory formulations. Natural compounds often have fewer adverse effects compared to synthetic drugs, making them more suitable for long-term use. These kinds of compounds can interact with biological targets in unique ways, potentially offering new therapeutic approaches. Centuries of ethnopharmacological use make plants an almost infinite source of potentially effective drugs in the treatment of inflammatory diseases.
We are pleased to invite you to contribute to our Special Issue Phytocompounds-Based Formulations for Anti-inflammatory Disorders. This Special Issue aims to highlight the most novel breakthroughs in the treatment of inflammatory conditions by phytocompounds. Research areas may include (but are not limited to) the following: natural or hemi-synthetic compounds, plant extracts and/or fractions, anti-inflammatory properties, conventional pharmaceutical forms, liposomes, nanocapsules, and/or drug targeting, applied to in vitro, in vivo, or in silico anti-inflammatory therapies.
I look forward to receiving your contributions.
Dr. Gustavo Costa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- phytocompounds
- natural compounds
- phytotherapy
- plant-based drugs
- anti-inflammatory
- pharmaceutical forms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
